The integrity of the blood–brain barrier is known to be compromised in CAA,17 and the CSF/blood albumin quotient correlates with the number of cerebral microbleeds in CAA (our own unpublished data) and Alzheimer's disease patients.18 This evidence concerns the gene ALB and early-onset autosomal dominant Alzheimer disease.